Neuren Pharmaceuticals | NEU - Capitale Ordinario

Prezzo Delle Azioni
11.48
Cambio Giornaliero
0.08 0.70%
Mensile
-12.23%
Annuale
-6.36%
Q1 Previsione
11.51




Capitale Ordinario Cambiamento Data
Akebia Therapeutics USD 2K 0 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Clinuvel Pharmaceuticals AUD 168.8M 754.23K 2024-06
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Genetic Signatures AUD 127.64M 8.22M 2024-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organon & Co USD 259.98M 18K 2025-09
Paradigm Biopharmaceuticals AUD 389.43M 136.19M 2025-06
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Starpharma Holdings AUD 419.92M 179.17M 2025-12
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09